Steven Cohen Krystal Biotech, Inc. Transaction History

Point72 Asset Management, L.P.

$36.6 Billion
Q3 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$96.0 - $128.29 $65.6 Million - $87.6 Million	-682,859 Reduced 97.81%	15,299 $1.9 Million
Q3 2023 Nov 14, 2023	BUY	$108.51 - $130.22 $15.1 Million - $18.1 Million	138,897 Added 24.84%	698,158 $81 Million
Q2 2023 Aug 14, 2023	BUY	$78.48 - $130.32 $4.46 Million - $7.41 Million	56,861 Added 11.32%	559,261 $65.7 Million
Q1 2023 May 15, 2023	SELL	$72.39 - $84.27 $3.9 Million - $4.54 Million	-53,852 Reduced 9.68%	502,400 $40.2 Million
Q4 2022 Feb 14, 2023	SELL	$63.14 - $79.9 $44.3 Million - $56.1 Million	-702,253 Reduced 55.8%	556,252 $44.1 Million
Q3 2022 Nov 14, 2022	SELL	$64.85 - $82.4 $20.5 Million - $26 Million	-315,770 Reduced 20.06%	1,258,505 $87.7 Million
Q2 2022 Aug 15, 2022	SELL	$48.93 - $73.47 $7.14 Million - $10.7 Million	-145,992 Reduced 8.49%	1,574,275 $103 Million
Q1 2022 May 16, 2022	SELL	$51.99 - $72.11 $7.06 Million - $9.8 Million	-135,889 Reduced 7.32%	1,720,267 $114 Million
Q4 2021 Feb 14, 2022	BUY	$39.81 - $88.24 $52.6 Million - $117 Million	1,321,456 Added 247.14%	1,856,156 $130 Million
Q3 2021 Nov 15, 2021	BUY	$52.01 - $71.77 $10.1 Million - $13.9 Million	193,800 Added 56.85%	534,700 $27.9 Million
Q2 2021 Aug 16, 2021	BUY	$62.14 - $81.82 $10.7 Million - $14.1 Million	171,900 Added 101.72%	340,900 $23.2 Million
Q1 2021 May 17, 2021	SELL	$59.42 - $85.46 $19.7 Million - $28.3 Million	-331,000 Reduced 66.2%	169,000 $13 Million
Q4 2020 Feb 16, 2021	SELL	$40.64 - $61.38 $6.66 Million - $10.1 Million	-163,889 Reduced 24.69%	500,000 $30 Million
Q3 2020 Nov 16, 2020	BUY	$37.76 - $48.49 $4.71 Million - $6.04 Million	124,647 Added 23.12%	663,889 $28.6 Million
Q2 2020 Aug 14, 2020	BUY	$37.03 - $60.0 $20 Million - $32.4 Million	539,242 New	539,242 $22.3 Million
Q3 2019 Nov 15, 2019	SELL	$34.72 - $51.3 $3.53 Million - $5.22 Million	-101,700 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$27.2 - $41.2 $479,155 - $725,779	17,616 Added 20.95%	101,700 $4.1 Million
Q1 2019 May 15, 2019	BUY	$19.86 - $32.9 $1.67 Million - $2.77 Million	84,084 New	84,084 $2.77 Million

Others Institutions Holding KRYS

# of Institutions

310

Shares Held

24.4M

Call Options Held

483K

Put Options Held

364K

Black Rock Inc. New York, NY

3.95M
Shares

$720 Million
0.02% of portfolio
Vanguard Group Inc Valley Forge, PA

2.85M
Shares

$519 Million
0.01% of portfolio
Avoro Capital Advisors LLC New York, NY

2.62M
Shares

$478 Million
7.18% of portfolio
State Street Corp Boston, MA

1.45M
Shares

$265 Million
0.01% of portfolio
Frazier Life Sciences Management, L.P. Menlo Park, CA

988K
Shares

$180 Million
9.67% of portfolio

View Full List

About Krystal Biotech, Inc.

Ticker KRYS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,664,300
Market Cap $4.68B
Description
Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...

More about KRYS

Track Steven Cohen's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Asset Management, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Point72 Asset Management, L.P. and Steven Cohen with notifications on news.

Account